Document is current

Article History

Accepted: 27 May 2024

First Online: 14 June 2024

Declarations

:

: No funding was received for the preparation of this article.

: Richard H. Woods is employed by a law firm that specializes in complex litigation. The firm is not involved in litigation concerning PCSK9 inhibitors or incomplete dosing-related complications associated with any medication. The firm had no role in the design, conduct, or funding of this study and does not endorse the results or conclusions presented therein.

: This retrospective observational study relied on publicly available, voluntary, de-identified adverse event reports. Therefore, ethical approval was not required.

: Not applicable.

: Not applicable.

: The data that support the findings of this study are publicly available and accessible via and .

: Certain portions of the coding used in conducting this study are available from the author upon reasonable request.

: All aspects of this study including conception, design, methodology, analysis, and writing were performed by RHW.